Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US12186404B2 · kind B2 · utility
0Cited by
7References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2022 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Jun 10, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject matter disclosed herein relates generally to cancer therapy and to anticancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target (X) R and their use in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.